Voyageur Pharmaceuticals Announces Proposed Issuance of Shares for Debt Calgary, Alberta--(Newsfile...

Voyageur Pharmaceuticals Announces Proposed Issuance of Shares for Debt Calgary, Alberta--(Newsfile Corp. - September 24, 2026) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company"), Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, announces that it proposes to settle debts in the aggregate amount of $192,300 (the "Debt") through the issuance of common shares of the Company ("Common Shares") at a deemed price of $0.155 per Common Share, being the closing price of the Common Shares on the TSX Venture Exchange (the "Exchange") on September 24, 2026.